The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis of Randomised Studies

The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis of Randomised Studies

Aim: Fibrates have proven efficacy in cardiovascular risk reduction and are commonly used, in addition to statins, to control hypertriglyceridaemia. Their use is often limited due to reduction in glomerular filtration rate at treatment initiation. However, recent studies suggest benign changes in ki...

Full description

Bibliographic Details
Main Authors:	Alexandros Hadjivasilis, Panayiotis Kouis, Andreas Kousios, Andrie Panayiotou
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Journal of Clinical Medicine
Subjects:	cardivacular disease renal function proteinuria fibrates
Online Access:	https://www.mdpi.com/2077-0383/11/3/768

Similar Items

Digital <i>h</i>-Fibrations and Some New Results on Digital Fibrations
by: Talip Can Termen, et al.
Published: (2024-03-01)

Fibrate and the risk of cardiovascular disease among moderate chronic kidney disease patients with primary hypertriglyceridemia
by: Chieh-Li Yen, et al.
Published: (2024-02-01)

Lipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention
by: Zhou Yu-Hao, et al.
Published: (2013-01-01)

Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study
by: Wen-Yu Ho, et al.
Published: (2022-11-01)

Can Concurrent Fibrate Use Reduce Cardiovascular Risks among Moderate Chronic Kidney Disease Patients Undergoing Statin Therapy? A Cohort Study
by: Li-Yi Ma, et al.
Published: (2023-12-01)

A Fibrational Method of Indexed Coinductive Data Types
by: Decheng Miao, et al.
Published: (2020-01-01)

Electrophoretic analysis (sds-page) of canine urinary proteins according to the stage of chronic kidney disease
by: L.T. Patitucci, et al.
Published: (2020-08-01)

Chronic kidney disease prevention campaign: relationship between proteinuria and elderly people
by: Júlio César Chaves Nunes Filho, et al.
Published: (2022-11-01)

Normalization of the levels of inflammatory molecules in Mycobacterium smegmatis-infected U937 cells by fibrate pretreatment
by: Sung-Jo Kim, et al.
Published: (2014-01-01)

Flavonoids and fibrate modulate apoE4-induced processing of amyloid precursor protein in neuroblastoma cells
by: Viralkumar Davra, et al.
Published: (2023-12-01)

Exploring the Symmetry of Curvilinear Regression Models for Enhancing the Analysis of Fibrates Drug Activity through Molecular Descriptors
by: Suha Wazzan, et al.
Published: (2023-05-01)

MIXED SERRE FIBRATION
by: Zahraa Yassin Habeeb, et al.
Published: (2022-09-01)

Structural Analysis of Human Serum Albumin in Complex with the Fibrate Drug Gemfibrozil
by: Stefano Liberi, et al.
Published: (2022-02-01)

Elucidating the Effects of the Lipids Regulators Fibrates and Statins on the Health Status of Finfish Species: A Review
by: Manuel Blonç, et al.
Published: (2023-02-01)

Lipoprotein Glomerulopathy, First Case Report from Canada
by: Ting JA, et al.
Published: (2022-06-01)

Design and synthesis of guaiacol-based fibrate derivatives with potential hypolipidemic and liver protective actions
by: Yan Zhang, et al.
Published: (2024-01-01)

Albumin-to-protein ratio in spot urine samples for analysis of proteinuria selectivity in chronic kidney disease
by: Miguel Augusto Martins Pereira, et al.
Published: (2022-10-01)

Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort
by: Farsad Afshinnia, et al.
Published: (2016-11-01)

A comprehensive analysis of albuminuria in canine chronic kidney disease
by: Karel Paukner, et al.
Published: (2024-03-01)

Impact of concomitant fibrates on immunotherapy outcomes for advanced non‐small cell lung cancer
by: William A. Stokes, et al.
Published: (2023-01-01)

Dengue-associated kidney disease
by: Karlo J Lizarraga, et al.
Published: (2014-04-01)

Correlation between markers of renal tubular injury and proteinuria in patients with diabetic kidney disease
by: Pu Yan, et al.
Published: (2024-04-01)

Continuation of fibrate therapy in patients with metabolic syndrome and COVID-19: a beneficial regime worth pursuing
by: Alpo Vuorio, et al.
Published: (2022-12-01)

Antifungal Activity of Fibrate-Based Compounds and Substituted Pyrroles That Inhibit the Enzyme 3-Hydroxy-methyl-glutaryl-CoA Reductase of Candida glabrata (CgHMGR), Thus Decreasing Yeast Viability and Ergosterol Synthesis
by: Damián A. Madrigal-Aguilar, et al.
Published: (2022-04-01)

Proteinuria and Electrophoretic Pattern in Dogs with Comorbidities Associated with Chronic Kidney Disease
by: Alicia Pamela Pérez-Sánchez, et al.
Published: (2023-04-01)

Fibrates: A Possible Treatment Option for Patients with Abdominal Aortic Aneurysm?
by: Naofumi Amioka, et al.
Published: (2022-01-01)

Associations among Heavy Metals and Proteinuria and Chronic Kidney Disease
by: Hui-Ju Tsai, et al.
Published: (2021-02-01)

A Graphic Method for Detecting Multiple Roots Based on Self-Maps of the Hopf Fibration and Nullity Tolerances
by: José Ignacio Extreminana-Aldana, et al.
Published: (2021-08-01)

Confirmation of Statin and Fibrate Use from Small-Volume Archived Plasma Samples by High-Throughput LC-MS/MS Method
by: Jennifer D. Kusovschi, et al.
Published: (2023-04-01)

Fibrates Affect Levels of Phosphorylated p38 in Intestinal Cells in a Differentiation-Dependent Manner
by: Katerina Cizkova, et al.
Published: (2023-04-01)

Presence of Non-Diabetic Kidney Diseases in Biopsy Specimens of Diabetic Patients’ Single Center Experience
by: Aleksandar Janković, et al.
Published: (2023-09-01)

Clinical Predictors of Preeclampsia in Pregnant Women with Chronic Kidney Disease
by: Bogdan Marian Sorohan, et al.
Published: (2020-04-01)

Intrarenal and Urinary Glycogen Synthase Kinase-3 Beta Levels in Diabetic and Nondiabetic Chronic Kidney Disease
by: Lingfeng Zeng, et al.
Published: (2023-03-01)

SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease
by: Manuel Alfredo Podestà, et al.
Published: (2023-01-01)

Weight loss has an additive effect on the proteinuria reduction of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease
by: Shin Young Ahn, et al.
Published: (2018-03-01)

Proteinuria is a risk factor for acute kidney injury after cardiac surgery in patients with stages 3–4 chronic kidney disease: a case control study
by: Wuhua Jiang, et al.
Published: (2023-02-01)

Cumulative non-HDL-cholesterol burden in patients with hypertriglyceridemia receiving long-term fibrate therapy: Real life data from a lipid clinic cohort
by: Meral Kayıkçıoğlu, et al.
Published: (2020-06-01)

A Rare Cause of Proteinuria: Sarcoidosis with Isolated Kidney and Muscle Involvement
by: Yelda DELİGÖZ BİLDACI, et al.
Published: (2023-12-01)

Risk of de novo proteinuria following hospitalization with acute kidney injury
by: Saniya S. Bonde, et al.
Published: (2023-06-01)

Remission of Proteinuria May Protect against Progression to Chronic Kidney Disease in Pediatric-Onset IgA Nephropathy
by: Jin-Soon Suh, et al.
Published: (2020-06-01)